Wellington Management Group
NERV icon

Wellington Management Group’s Minerva Neurosciences NERV Stock Holding History

Wellington Management Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-76,632
Closed -$4.82M – 2101
2019
Q1 		$4.82M Hold
76,632
– – ﹤0.01% 1386
2018
Q4 		$4.13M Buy
76,632
+61,385
+403% +$4.49M ﹤0.01% 1439
2018
Q3 		$1.53M Buy
+15,247
New +$1.15M ﹤0.01% 1781

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Management Group's NERV Position: Q2 2019 in Review

Wellington Management Group sold out of Minerva Neurosciences (NERV) in Q2 2019, closing a stake of 76,632 shares — an estimated $4.82M sold.

Wellington Management Group first reported a position in NERV in Q3 2018 and held it in 3 quarters. The position peaked at $4.82M in Q1 2019. 85 funds tracked by Wall St. Rank hold NERV as of Q2 2019.

  • Wellington Management Group reported no remaining Minerva Neurosciences position as of Q2 2019 after selling out during the quarter.
  • Wellington Management Group sold 76,632 Minerva Neurosciences shares in Q2 2019, an estimated $4.82M.
  • Wellington Management Group first reported a position in Minerva Neurosciences in Q3 2018 and held it in 3 quarters.
  • Wellington Management Group's Minerva Neurosciences position peaked at $4.82M in Q1 2019.
  • 85 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2019.

Based on Wellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.